- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology-10-02-2007
Pharmaceutical Technology
Advances in Transdermal Technologies
October 02, 2007
Special Report
31
10
Transdermal delivery takes up once-forbidden compounds, reviving markets and creating formulation opportunities.
Manufacturing One Trend at a Time
October 02, 2007
Viewpoint
31
10
Change is inevitable, as is contract manufacturing. But which companies will survive the drifts?
In the Spotlight October 2007
October 02, 2007
In the Spotlight
31
10
Carl Zeiss MicroImaging (Thornwood, NY) recently introduced its "Colibri" light-emitting diode (LED) light source for fluorescence microscopy. The product is "the only LED light source optimized for white-field microscopy systems," says Becky Homan, product manager for biomedical light microscopy.
Pharma Capsules
October 02, 2007
Pharma Capsules
31
10
Lancaster Laboratories (Lancaster, PA) acquired Microchem Laboratories (Waterford, Ireland). Microchem was established in 1986 and is one of Ireland's testing and research laboratories. Microchem offers microbiological, chemical, and environmental analyses to the pharmaceutical, medical-device, and chemical industries in Europe and Asia.
Functionality-Related Characteristics of Excipients
October 02, 2007
Peer-Reviewed Research
31
10
Amidst debate, the European Pharmacopoeia Commission is working to include physical or "functionality-related characteristics" of exipient materials in its monographs.
Sustainable Packaging Resources
October 02, 2007
Online Exclusive
31
10
When it comes to designing and sourcing sustainable packaging, there are no simple answers. Sustainable packaging depends on a complex interaction of environmental, social, and economic considerations, which are influenced by geography and other factors such as renewability, compostability, biodegradability, weight, and performance.
In the Field
October 02, 2007
In the Field
31
10
The United States House of Representatives passed its version of the Patent Reform Act of 2007 (H.R. 1908) in September in a 220-175 vote. Although the bill aims to fix current flaws in the US patent system and to bring it in line with those of other countries' systems, the biopharmaceutical industry is largely unhappy with the news, arguing that it will reduce patent protection.
The Application of Quality by Design to Analytical Methods
October 02, 2007
Peer-Reviewed Research
31
10
To monitor and control processes or products, analytical methodology must be fit for purpose. An approach to apply quality by design principles to the design and evaluation of analytical methods has therefore been developed to meet these needs. This article features a downloadable template on which to conduct a failure mode effect analysis (FMEA).
Avoiding Subprime Contractors and Contracts
October 02, 2007
Outsourcing
31
10
Could sloppy due diligence practices hurt CMOs and their clients?
Agent in Place: Vials and Villains
October 02, 2007
Agent-In-Place
31
10
Our files pull up lost contracts, poor competitive tactics, and an over-ambitious employee.
Converting Intravenous Dosing to Subcutaneous Dosing With Recombinant Human Hyaluronidase
October 02, 2007
Peer-Reviewed Research
31
10
The preferred route of administration for an injected therapeutic agent is subcutaneous (SC), but SC injections are generally limited to no more than 1-2 mL in volume, representing a major challenge, especially for large protein biologics.
Packagers Pursue Sustainability
October 02, 2007
Packaging Forum
31
10
Nonpharmaceutical manufacturers find ways to make environmentally sound packaging.
Charting a Path to Purity
October 02, 2007
Book Review
31
10
Regulators and industry professionals provide a guide for identifying and measuring impurities.
Who's in Charge?
October 02, 2007
From The Editor
31
10
Courts are denying the terminally ill access to experimental drugs, leaving many with no options.
We Need More Overseas Inspections
October 02, 2007
This Time Around
31
10
Offshore contracting is nothing new for the pharmaceutical industry. Neither is importing active ingredients, or prescription drugs, for that matter. But the authorities are having trouble keeping up with these growing international trends.
Strategy for the Prediction and Selection of Drug Substance Salt Forms
October 02, 2007
Peer-Reviewed Research
31
10
Through consideration of the ionic equilibria of acids and bases, one may readily calculate the formation constant of a salt species solely on the basis of knowledge of the pKA value of the acid and the pKB value of the base.
Advancing ODT Technology
October 02, 2007
Articles
31
10
Orally disintegrating tablets (ODTs) continue to attract attention as an alternative to conventional oral dosage forms.
Medicare Drug Benefit Boosts Pharmaceutical Use
October 02, 2007
Washington Report
31
10
Expanded access to drugs for seniors has increased demand and focused attention on costs.
Materials of Construction Based on Recovery Data for Cleaning Validation
October 02, 2007
Peer-Reviewed Research
31
10
The material of construction is a factor in the recovery of residue in cleaning validation. An analysis of existing recovery data showed that recovery factors for drug products on various materials of construction may be categorized into several groupings.
Acceptance Limits for the New ICH USP 29 Content-Uniformity Test
October 02, 2007
Peer-Reviewed Research
31
10
Revisions to the United States Pharmacopeia's (USP) uniformity test require manufacturers to establish new acceptance limits. The authors present their method for calculating acceptance limits consistent with USP's revised content-uniformity test requirements.